Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Fatih M. Uckun(University of Southern California), Nyla A. Heerema(The Ohio State University), Paul S. Gaynon(University of Southern California), Peter G. Steinherz(Memorial Sloan Kettering Cancer Center), L Tuel-Ahlgren(Parker Hughes Cancer Center), Mya-Lisa Crotty(Parker Hughes Cancer Center), Mireille Sarquis(Parker Hughes Cancer Center), James B. Nachman(University of Chicago), Bruce Bostrom(Minnesota West Community & Technical College), Harland N. Sather(Children's Oncology Group), Martha G. Sensel(Parker Hughes Cancer Center)
Cited by 122
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2001|825